Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome
Clinical trial NCT04402541 · COMPLETED
Trial details
- NCT number
- NCT04402541
- Sponsor
- Cleave Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-08
- Primary completion
- 2023-07-23
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.